Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)
Published April 13, 2022 · Recall initiated: March 31, 2022
Summary
FDA records drug Class II recall D-0746-2022, published April 13, 2022 and initiated March 31, 2022. Recalling firm: MERCK SHARP & DOHME CORP; Status: Terminated; Reported quantity: 3600 cartons; Lot: Lot: U015824, Exp. 09/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance: Presence of stainless steel particulates in tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if JANUMET has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- JANUMET
- Manufacturer
- MERCK SHARP & DOHME CORP
- Distributor
- Nationwide in the USA
- UPC
- 0300060575617
- Lot
- Lot: U015824, Exp. 09/22.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDA23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503BApril 13, 2022
- FDANETSPOT (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, kit contains Vial 1 (ReactionApril 13, 2022
- FDAPHENOBARBITAL Sodium Injection, USP, 130 mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-416-25) andApril 13, 2022
- FDATravoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan PharmaceuticalsApril 13, 2022
- FDAPHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b)April 13, 2022
- FDASucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) andApril 13, 2022
Questions about this recall
Was Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03) recalled?
Yes. FDA published recall D-0746-2022 on April 13, 2022. Reported hazard: Presence of foreign substance: Presence of stainless steel particulates in tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: JANUMET. UPC: 0300060575617.